Top Markets
Coin of the day
SD BioSensor, Inc SD BioSensor, Inc

SD BioSensor, Inc

137310
Rank in Stocks #13260
SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced... SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.
Share Price
$4.23
Market Cap
$506.22M
Change (1 day)
-2.86%
Change (1 year)
-41.34%
Country
KR
Trade SD BioSensor, Inc (137310)

Category

Revenue for SD BioSensor, Inc (137310)
Revenue in Aug 2026 TTM: 0
According to SD BioSensor, Inc latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for SD BioSensor, Inc from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$11.03B -
US
$34.74B -
FR
- -
JP
$20.84B -
US
- -
CH